Totally. Sirtex does not have the troubling issue of weakness and side effects of other treatments. This is definitely the future as more and more patients would rather treatments that are not painful and do not exhaust them during and after treatment. But man, it's all about the next breakout level. Its looks like one of the new comers that are sure to do well
- Forums
- ASX - By Stock
- Why OSL is a Multi-Bagger
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(6.67%) |
Mkt cap ! $35.79M |
Open | High | Low | Value | Volume |
0.8¢ | 0.9¢ | 0.8¢ | $135.0K | 16.89M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
65 | 28847611 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 500000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
65 | 28847611 | 0.007 |
23 | 9359399 | 0.006 |
18 | 15830198 | 0.005 |
9 | 9262824 | 0.004 |
2 | 2839966 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 500000 | 1 |
0.009 | 10737751 | 12 |
0.010 | 13113723 | 14 |
0.011 | 9139301 | 17 |
0.012 | 7560752 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online